MPWT
LENZ

MassMutual Private Wealth & Trust’s LENZ Therapeutics LENZ Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-245
Closed -$3.92K – 2516
2025
Q4 		$3.92K Buy
245
+165
+206% +$4.81K ﹤0.01% 1775
2025
Q3 		$3.73K Buy
80
+17
+27% +$625 ﹤0.01% 1787
2025
Q2 		$1.85K Buy
+63
New +$1.71K ﹤0.01% 1970

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

MassMutual Private Wealth & Trust's LENZ Position: Q1 2026 in Review

MassMutual Private Wealth & Trust sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 245 shares — an estimated $3.92K sold.

MassMutual Private Wealth & Trust first reported a position in LENZ in Q2 2025 and held it in 3 quarters. The position peaked at $3.92K in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • MassMutual Private Wealth & Trust reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 245 LENZ Therapeutics shares in Q1 2026, an estimated $3.92K.
  • MassMutual Private Wealth & Trust first reported a position in LENZ Therapeutics in Q2 2025 and held it in 3 quarters.
  • MassMutual Private Wealth & Trust's LENZ Therapeutics position peaked at $3.92K in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2026, filed 13 Apr 2026.